Fakhrinnisa Tamara Aulia, Susilo Imam, Mustika Arifa, Sofyan Miyayu Soneta
Medicine Undergraduate Program, Faculty of Medicine, Airlangga University, Jalan Mayjen Prof. Dr. Moestopo 47, Surabaya, Indonesia.
Department of Pathological Anatomy, Faculty of Medicine, Airlangga University, Jalan Mayjen Prof. Dr. Moestopo 47, Surabaya, Indonesia.
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):457-462. doi: 10.31557/APJCP.2021.22.2.457.
Cisplatin is potent chemotherapy for broad-spectrum malignancies treatment, but its use is limited by organ toxicity effects, including nephrotoxicity. Glutamine prevents cisplatin nephrotoxicity by inhibiting the oxidative stress in kidney cell apoptosis.
This research examined the nephroprotective effects of intravenous glutamine on the glomerular epithelium of male rats (Rattus norvegicus). 30 male rats were randomly divided into (1) P0 as the control group; (2) P1 that was administered with single dose cisplatin (20 mg/kg BW) intraperitoneal injection; and (3) P2 that was administered with intravenous injection of glutamine (100 mg/kg BW) and single-dose cisplatin (20 mg/kg BW) intraperitoneal injection. The measurement of caspase-12 expression and apoptotic cells was performed using immunohistochemical methods.
The caspase-12 expression are as follows: P0 = 0.5 ± 0.15; P1 = 4.1 ± 0.86; P2 = 2.54 ± 0.72. The apoptotic cells are as follows: P0 = 14.5 ± 5.23 cells/field of view; P1 = 52.7 ± 17.06 cells/field of view; P2 = 31.5 ± 6.73 cells/field of view. There is a decrease in the caspase-12 expression and apoptotic cells after intravenous glutamine administration in male white rats' glomerular epithelial cells exposed to cisplatin. The decrease of caspase-12 expression is followed by a decrease in glomerular epithelium apoptosis after intravenous glutamine administration.
Immunohistochemical examination can be used as a marker of the nephrotoxic effect of cisplatin on the renal glomerular epithelium. Glutamine has been observed to give nephroprotective effect to cisplatin nephrotoxic effects.
.
顺铂是用于治疗多种恶性肿瘤的有效化疗药物,但其应用受到包括肾毒性在内的器官毒性作用的限制。谷氨酰胺通过抑制肾细胞凋亡中的氧化应激来预防顺铂肾毒性。
本研究检测静脉注射谷氨酰胺对雄性大鼠(褐家鼠)肾小球上皮的肾保护作用。30只雄性大鼠随机分为:(1)P0作为对照组;(2)P1腹腔注射单剂量顺铂(20mg/kg体重);(3)P2静脉注射谷氨酰胺(100mg/kg体重)并腹腔注射单剂量顺铂(20mg/kg体重)。采用免疫组织化学方法检测半胱天冬酶-12表达和凋亡细胞。
半胱天冬酶-12表达情况如下:P0 = 0.5±0.15;P1 = 4.1±0.86;P2 = 2.54±0.72。凋亡细胞情况如下:P0 = 14.5±5.23个细胞/视野;P1 = 52.7±17.06个细胞/视野;P2 = 31.5±6.73个细胞/视野。在暴露于顺铂的雄性白鼠肾小球上皮细胞中静脉注射谷氨酰胺后,半胱天冬酶-12表达和凋亡细胞减少。静脉注射谷氨酰胺后,半胱天冬酶-12表达降低,随后肾小球上皮细胞凋亡减少。
免疫组织化学检查可作为顺铂对肾小球上皮肾毒性作用的标志物。已观察到谷氨酰胺对顺铂肾毒性具有肾保护作用。